Pharma Intelligence is part of the Informa Intelligence Division of Informa PLC
This is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Principal Analyst
USA
15+ years of experience
Heidi Chen 08 Nov 2019
Recent news of the Ohio State ruling on the opioid litigation trial against Johnson & Johnson shed new light on the complex opioid addiction crisis in the US.
Heidi Chen 11 Jun 2019
Twenty years ago, there was a shift in pain management, and it became more common to prescribe opioids for chronic pain.
Trialtrove
By Heidi Chen 30 Nov 2017
Over the last decade, it is undeniable that China has emerged as a rising star in pharmaceutical R&D
Topic Clinical Trials
Trialtrove
By Heidi Chen 01 Oct 2015
One of the most common approaches in abuse-deterrent technology is the development of new formulations of extended-release opioids, or tamper resistant properties that render the drugs difficult to crush, grind, and dissolve for injection or nasal insufflation by potential abusers.
Topic Approvals Drug Review
